Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Medical Oncology (Northwood, London, England)
|
June 18, 2022
Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes
Canping Chen, Jiangti Luo, Xiaosheng Wang
Human Genetics
|
June 1, 2026
ScSpTITH: a rank-correlation framework for robust quantification of multi-dimensional tumor heterogeneity
Jiangti Luo, Qiqi Lu, Xiaobo Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 11, 2023
Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
Jiali Lei, Jiangti Luo, Qian Liu, et al.
Frontiers in Cell and Developmental Biology
|
January 23, 2023
The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
Jiangti Luo, Canping Chen, Zhixian Liu, et al.
Biomolecules
|
January 21, 2023
Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling
Qiqi Lu, Rongfang Nie, Jiangti Luo, et al.
Frontiers in Pharmacology
|
April 7, 2025
Identifying acute myeloid leukemia subtypes based on pathway enrichment
Ling Zhong, Jiangti Luo, Junze Dong, et al.
NPJ Precision Oncology
|
December 16, 2025
Quantitative profiling of intratumor immune heterogeneity identifies loss of immune diversity as a hallmark of cancer progression
Qiqi Lu, Jiangti Luo, Chia-Hao Tung, et al.
Computers in Biology and Medicine
|
April 25, 2024
Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes
Zeinab Abdelrahman, Alaa Abdelatty, Jiangti Luo, et al.
Computational and Structural Biotechnology Journal
|
June 22, 2026
QeITH: Quantifies Tumor Ecosystem Heterogeneity to Predict Cancer Progression and Treatment Benefit
Qiqi Lu, Jiangti Luo, Jiawei Wang, et al.
International Immunopharmacology
|
July 31, 2021
Subtyping of head and neck squamous cell cancers based on immune signatures
Dandan Song, Haoyu Lyu, Qiushi Feng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Medical Oncology (Northwood, London, England)
|
June 18, 2022
Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes
Canping Chen, Jiangti Luo, Xiaosheng Wang
Human Genetics
|
June 1, 2026
ScSpTITH: a rank-correlation framework for robust quantification of multi-dimensional tumor heterogeneity
Jiangti Luo, Qiqi Lu, Xiaobo Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 11, 2023
Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
Jiali Lei, Jiangti Luo, Qian Liu, et al.
Frontiers in Cell and Developmental Biology
|
January 23, 2023
The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
Jiangti Luo, Canping Chen, Zhixian Liu, et al.
Biomolecules
|
January 21, 2023
Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling
Qiqi Lu, Rongfang Nie, Jiangti Luo, et al.
Frontiers in Pharmacology
|
April 7, 2025
Identifying acute myeloid leukemia subtypes based on pathway enrichment
Ling Zhong, Jiangti Luo, Junze Dong, et al.
NPJ Precision Oncology
|
December 16, 2025
Quantitative profiling of intratumor immune heterogeneity identifies loss of immune diversity as a hallmark of cancer progression
Qiqi Lu, Jiangti Luo, Chia-Hao Tung, et al.
Computers in Biology and Medicine
|
April 25, 2024
Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes
Zeinab Abdelrahman, Alaa Abdelatty, Jiangti Luo, et al.
Computational and Structural Biotechnology Journal
|
June 22, 2026
QeITH: Quantifies Tumor Ecosystem Heterogeneity to Predict Cancer Progression and Treatment Benefit
Qiqi Lu, Jiangti Luo, Jiawei Wang, et al.
International Immunopharmacology
|
July 31, 2021
Subtyping of head and neck squamous cell cancers based on immune signatures
Dandan Song, Haoyu Lyu, Qiushi Feng, et al.
Page
of 2